RESUMO
Exploration of the effects of "minor" structural differences on the antitumor activity and toxicity of dimeric Catharanthus alkaloids resulted in the preparation of deacetylvinblastine amide (vindesine, VDS) from either vinblastine (VLB) or deacetylvinblastine. Adequate amounts of vindesine for biological testing were prepared by preferential hydrazinolysis of the C23-ester in the vindoline moiety of VLB, followed by hydrogenolysis of the resulting deacetylvinblastine hydrazide. Vindesine in its activity spectrum against rodent tumor systems resembles vincristine (VCR) rather than its parent VLB, while its neurotoxic potential appears to be less than that of VCR. The experimental models developed to estimate this potential include in vitro measurements of axoplasmic transport effects in the cat sciatic nerve and the estimation of neuromuscular disturbances in chickens and monkeys by vindesine in comparison with VCR. A radioimmunoassay for VLB, VCR, and VDS, developed by means of deacetylvinblastine acid azide, has been used to study the pharmacokinetics of vindesine in man. The clinical investigation of vindesine is in progress. Deacetylvinblastine, in contrast to earlier reports, showed activity against several murine tumor systems.
Assuntos
Vimblastina/análogos & derivados , Animais , Pressão Sanguínea/efeitos dos fármacos , Gatos , Galinhas , Haplorrinos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Técnicas In Vitro , Cinética , Dose Letal Mediana , Leucemia Experimental/tratamento farmacológico , Masculino , Camundongos , Camundongos Endogâmicos , Neoplasias Experimentais/tratamento farmacológico , Ratos , Respiração/efeitos dos fármacos , Relação Estrutura-Atividade , Vimblastina/síntese química , Vimblastina/metabolismo , Vimblastina/farmacologiaRESUMO
The tolerability and potential target organ toxicity of rhIL-6 administered subcutaneously (s.c.) with rhGM-CSF or rhG-CSF were investigated in healthy nonhuman primates. Fifteen Rhesus monkeys were randomized to receive one of the following five regimens: rhIL-6, rhGM-CSF, rhG-CSF, rhIL-6 and rhGM-CSF, or rhIL-6 and rhG-CSF. Each cytokine was administered s.c. once daily at 20 micrograms/kg/day for 30-31 days. Marked increases in blood leukocyte counts (predominantly neutrophils) were observed in the rhGM-CSF and rhG-CSF treatment groups, but only a mild trend toward increased WBCs was observed with rhIL-6 alone. Platelet counts increased 1.7- to 2.2-fold in the rhIL-6 and rhGM-CSF groups. All regimens were well tolerated. RhIL-6, alone or in combination with either CSF, had no significant toxic effects at the dosages tested. Minimal to moderate bone marrow hyperplasia was observed in all except rhIL-6-treated animals, which correlated well with peripheral blood increases in WBCs. RhIL-6-treated animals demonstrated increased fibrinogen concentrations and erythrocyte sedimentation rates, decreased serum albumin/globulin ratios, and increased serum alpha-2-macroglobulin concentrations. Increased synthesis of acute-phase proteins was not observed in the other groups. Combining rhIL-6 with rhGM-CSF or rhG-CSF may reduce the rhIL-6-mediated acute-phase response while maintaining the desirable hematopoietic effects of the stimulating factors.
Assuntos
Sangue/efeitos dos fármacos , Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Fator Estimulador de Colônias de Granulócitos e Macrófagos/administração & dosagem , Interleucina-6/toxicidade , Animais , Sedimentação Sanguínea/efeitos dos fármacos , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Injeções Subcutâneas , Interleucina-6/administração & dosagem , Macaca mulatta , Masculino , Distribuição Aleatória , Albumina Sérica/efeitos dos fármacosRESUMO
OBJECTIVE: To determine sources of Salmonella organisms in a veterinary teaching hospital, compare bacterial culture with polymerase chain reaction (PCR) testing for detection of Salmonella organisms in environmental samples, and evaluate the effects of various disinfectants on detection of Salmonella organisms on surface materials. DESIGN: Prospective study. SAMPLE POPULATION: Fecal samples from 638 hospitalized horses and 783 environmental samples. PROCEDURE: Standard bacterial culture techniques were used; the PCR test amplified a segment of the Salmonella DNA. Five disinfectants were mixed with Salmonella suspensions, and bacterial culture was performed. Swab samples were collected from 7 surface materials after inoculation of the surfaces with Salmonella Typhimurium, with or without addition of a disinfectant, and submitted for bacterial culture and PCR testing. RESULTS: Salmonella organisms were detected in fecal samples from 35 (5.5%) horses. For environmental samples, the proportion of positive bacterial culture results (1/783) was significantly less than the proportion of positive PCR test results (110/783), probably because of detection of nonviable DNA by the PCR test. Detection of Salmonella organisms varied with the surface material tested, the method of detection (bacterial culture vs PCR testing), and the presence and type of disinfectant. CONCLUSIONS AND CLINICAL RELEVANCE: Results of the present study suggested that Salmonella organisms can be isolated from feces of hospitalized horses and a variety of environmental surfaces in a large animal hospital. Although recovery of Salmonella organisms was affected by surface material and disinfectant, bleach was the most effective disinfectant on the largest number of surfaces tested.
Assuntos
Portador Sadio/veterinária , Desinfetantes/farmacologia , Doenças dos Cavalos/microbiologia , Salmonelose Animal/microbiologia , Salmonella/isolamento & purificação , Animais , Portador Sadio/diagnóstico , Portador Sadio/microbiologia , DNA Bacteriano/análise , Fezes/microbiologia , Doenças dos Cavalos/diagnóstico , Doenças dos Cavalos/prevenção & controle , Cavalos , Hospitais Veterinários , Hospitais de Ensino , Técnicas Microbiológicas/métodos , Técnicas Microbiológicas/veterinária , Reação em Cadeia da Polimerase/veterinária , Estudos Prospectivos , Salmonella/efeitos dos fármacos , Salmonella/genética , Salmonelose Animal/diagnóstico , Salmonelose Animal/prevenção & controleAssuntos
Bacillus subtilis/efeitos dos fármacos , Bacillus/efeitos dos fármacos , Glicóis/farmacologia , Bacillus/crescimento & desenvolvimento , Bacillus subtilis/crescimento & desenvolvimento , Meios de Cultura , Polietilenos/farmacologia , Esporos/efeitos dos fármacos , Esporos/crescimento & desenvolvimentoAssuntos
Penicilina G Procaína , Reologia , Benzoatos , Química Farmacêutica , Citratos , Fosfatidilcolinas , Polietilenos , Tensoativos , Suspensões , ViscosidadeAssuntos
Doenças do Gato , Peritonite/veterinária , África , Anemia/complicações , Anemia/veterinária , Animais , Contagem de Células Sanguíneas/veterinária , Proteínas Sanguíneas/análise , Doenças do Gato/complicações , Doenças do Gato/diagnóstico , Doenças do Gato/epidemiologia , Gatos , Doença Crônica , Depressão , Diagnóstico Diferencial , Exsudatos e Transudatos/análise , Transtornos da Alimentação e da Ingestão de Alimentos/complicações , Transtornos da Alimentação e da Ingestão de Alimentos/veterinária , Humanos , Peritonite/complicações , Peritonite/diagnóstico , Peritonite/epidemiologia , Doenças Pleurais/complicações , Doenças Pleurais/veterinária , Derrame Pleural , Gravidade Específica , Estados UnidosRESUMO
The HMG-CoA reductase inhibitors are a new and novel class of cholesterol-lowering agents which are widely used worldwide. Fluvastatin is the first entirely synthetic compound in this class and is structurally distinct from fungal metabolite derivatives which are already marketed. As the liver is the site of some toxic effects for these compounds, it was not entirely unexpected that liver cancer was found in rats and/or mice with the first three marketed compounds, lovastatin, pravastatin, and simvastatin. Four lifetime carcinogenicity studies (two rat and two mouse) did not give any evidence that fluvastatin induced liver tumors in rodents. Fluvastatin induced thyroid neoplasms in rats and forestomach papillomas in rodents, as other compounds in this pharmacologic class have also done. The genotoxic potential of fluvastatin has been assessed in vitro using Salmonella typhimurium, Escherichia coli (gene mutations), V79 Chinese hamster cells (HGPRT gene mutations, chromosomal aberrations), rat hepatocyte primary cultures (DNA repair), and BALB/3T3 cells (malignant transformations). Fluvastatin was also tested in vivo for clastogenicity using the mouse bone marrow micronucleus test and by performing a cytogenetic analysis in the rat bone marrow after acute and subacute treatment. In all seven assays fluvastatin was found to be free of any genotoxic potential.
Assuntos
Anticolesterolemiantes/toxicidade , Carcinógenos/toxicidade , Ácidos Graxos Monoinsaturados/toxicidade , Indóis/toxicidade , Mutagênicos/toxicidade , Células 3T3 , Animais , Bactérias/efeitos dos fármacos , Testes de Carcinogenicidade , Transformação Celular Neoplásica , Células Cultivadas/efeitos dos fármacos , Cricetinae , Cricetulus , Citogenética , Reparo do DNA , Feminino , Fluvastatina , Masculino , Camundongos , Camundongos Endogâmicos , Testes para Micronúcleos , Testes de Mutagenicidade , Ratos , Ratos EndogâmicosRESUMO
A rare spontaneous tumor was detected in the kidney of an 11-mo-old beagle dog. The tumor was a well-circumscribed cortical mass and was composed of a heterogeneous population of connective tissue cell types. While the primary cell type was a spindle cell associated with prominent collagen deposition, other areas contained bands of smooth muscle cells and poorly cellular myxomatous tissue. The presence of smooth muscle cells was confirmed by transmission electron microscopy and immunoperoxidase techniques. Based on the results, the tumor was diagnosed as a benign mixed mesenchymal tumor.
Assuntos
Doenças do Cão/patologia , Neoplasias Renais/patologia , Neoplasias Renais/veterinária , Mesenquimoma/patologia , Mesenquimoma/veterinária , Animais , Cães , FemininoRESUMO
Bodies similar to acidophilic intracytoplasmic inclusions were found by light microscopy in the pancreatic acinar cells of 56 of 174 (32%) healthy male and female purebred Beagles and 14 of 97 (14%) of healthy male mongrel dogs. The inclusions were ovoid, acidophilic and often granular with basophilic particulates. Many seemed to be enclosed within halos of various widths. Electron microscopically the inclusions consisted of whorls of rough endoplasmic reticulum, vacuoles, and cytoplasmic organelles in various stages of decomposition. These inclusion bodies were interpreted as evidence of focal intracytoplasmic degradation. They appeared similar to the dense ribosomal autophagic vacuoles, hitherto described only in association with various experimental procedures.
Assuntos
Cães/anatomia & histologia , Corpos de Inclusão/ultraestrutura , Pâncreas/ultraestrutura , Animais , Retículo Endoplasmático/ultraestrutura , Feminino , Masculino , Microcorpos/ultraestrutura , Vacúolos/ultraestruturaRESUMO
A computerized operator-interactive system for measurement of atheroma is described. The system utilizes a 64K microcomputer, a high resolution digitizer tablet, dual floppy disc drives, and a video monitor. The method offers significant advantages over earlier systems in speed, accuracy, reproducibility and cost effectiveness.
Assuntos
Arteriosclerose/patologia , Computadores , Microcomputadores , Animais , Aorta/patologia , Análise Custo-Benefício , Coelhos , Coloração e RotulagemRESUMO
Three different sieve size fractions of ergot-containing biodegradable microcapsules were examined both in vitro and in vivo. The sieve sizes and average particle diameter, (micron), were: less than 45-75 (mean = 30); 75-106 (mean = 79); 106-177 (mean = 130). These microcapsules contained ca. 9% drug and were produced from 50:50 poly(DL-lactide-co-glycolide). The objective was to determine the effect of particle size on in vivo and in vitro degradation rates. The microcapsules were injected into rat gastrocnemius muscle and excised and examined at various time points up to 70 days. Initially a minimal tissue response was noted which was characterized by a sharply localized acute inflammatory reaction. Following this, connective tissue and foreign body giant cells engulfed the microcapsules at 20-30 days. Only vestiges of the microcapsules were found surrounded by minimal connective tissue and foreign body giant cells after 60-70 days. The tissue reaction was a minimal, sharply localized foreign body giant cell and connective tissue process for all three size groups of microcapsules. The largest microcapsules (mean = 130 microns) exhibited a slightly greater tendency to undergo in vivo and in vitro degradation relative to the other groups. However, it can be concluded that over the microcapsule size ranges examined minimal differences in the degradation properties of the polymeric matrices and consequently those of the microcapsules were noted.
Assuntos
Materiais Biocompatíveis , Ácido Láctico , Ácido Poliglicólico , Polímeros , Animais , Biodegradação Ambiental , Cápsulas , Masculino , Microscopia Eletrônica de Varredura , Músculos/citologia , Músculos/ultraestrutura , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Ratos , Ratos Endogâmicos , Fatores de TempoRESUMO
The biodegradation of the copolymer 50:50 poly(DL-lactide-co-glycolide)-lypressin microcapsules was studied by light and electron microscopic methods and 14C release. Intramuscular injection sites of microcapsules in rats were studied by dissecting and conventional light microscopy as well as scanning (SEM) and transmission electron microscopy. A minimal localized acute myositis was seen initially at the injection sites. By Day 4, a few small foreign body giant cells were present participating in the minimal foreign body response. Later the inflammatory cells decreased and the individual microcapsules were walled off by immature fibrous connective tissue and large syncytial foreign body giant cells. By Day 35, definitive changes in some microcapsules, consisting of a granular and slightly eroded appearance of the internal matrix, were seen by SEM. By Day 42, the outer rims of the microcapsules were extensively eroded. At Day 56, the inflammatory and connective tissue reactions were almost completely resolved and biodegradation continued so that only remnant pieces of the microcapsules were present at Day 63. The morphologic picture correlated well with loss of 14C radioactivity, which could no longer be detected at the injection sites on Day 56. Phagocytosis did not seem to be an important factor in the biodegradation.
Assuntos
Cápsulas , Poliglactina 910/metabolismo , Polímeros/metabolismo , Animais , Biodegradação Ambiental , Radioisótopos de Carbono , Injeções Intramusculares , Masculino , Microscopia Eletrônica , Microscopia Eletrônica de Varredura , Músculos/metabolismo , Músculos/patologia , Miosite/induzido quimicamente , Miosite/patologia , Ratos , Ratos Endogâmicos , Fatores de TempoRESUMO
Fluvastatin is a potent synthetic competitive inhibitor of beta-hydroxy-beta-methyl-glutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in the biosynthetic pathway for hepatic cholesterol synthesis. The therapeutic indication is reduction of elevated total and low-density lipoprotein cholesterol levels. Results from four toxicity studies in beagle dogs and one study in rhesus monkeys following oral administration of fluvastatin are reported. In two 26-week dog studies, doses were 0, 1, 8, or 48 mg/kg/day (reduced to 36 mg/kg/day in Week 7) and 0, 6, 24, or 36 mg/kg/day (reduced to 30 mg/kg/day in Week 2). In a 2-year dog study, doses were 0, 1, 8, or 16 mg/kg/day. Dose levels in the 26-week monkey study were 0, 0.6, 12, and 48 mg/kg/day (raised to 84 mg/kg/day in Week 17 and to 108 mg/kg/day in Week 22). In these studies, evaluations included clinical and physical examinations, body weight and food consumption, electrocardiography, ophthalmoscopy, hematology and clinical chemistries, urinalysis, blood drug concentration, and macroscopic and microscopic examinations of observed lesions and representative tissues. In the 26- and 52-week dog studies and the monkey study, lenticular biochemistry, the HMG-CoA reductase activity of liver microsomes, and serum lipid concentrations were investigated. The fourth dog study was a single-dose toxicokinetic study in which 48 mg/kg [3H]-fluvastatin was monitored for up to 2 weeks. Sampling was limited to ocular tissues for enzyme analysis. Doses of > or = 24 mg/kg/day were lethal in dogs. At lethal doses, ataxia, convulsions, fecal blood, multifocal congestion and hemorrhage, isolated foci of malacia in the medulla oblongata, and liver necrosis were observed. Reduced weight gain, emesis, cataracts, elevated liver enzymes, reduced cholesterol, and gallbladder inflammation with mucosal hyperplasia occurred at > or = 8 mg/kg/day. In contrast to other HMG-CoA reductase inhibitors, fluvastatin did not cause significant central nervous system hemorrhage or testicular changes in dogs. Monkeys tolerated exposure to fluvastatin well with only mild gallbladder changes observed. Reduced serum cholesterol and slight hyperplasia of the gallbladder mucosa occurred in the 12 and 48/84/108 mg/kg/day groups.
Assuntos
Ácidos Graxos Monoinsaturados/toxicidade , Inibidores de Hidroximetilglutaril-CoA Redutases , Indóis/toxicidade , Administração Oral , Animais , Peso Corporal/efeitos dos fármacos , Catarata/induzido quimicamente , Cães , Ingestão de Alimentos/efeitos dos fármacos , Ácidos Graxos Monoinsaturados/administração & dosagem , Ácidos Graxos Monoinsaturados/química , Ácidos Graxos Monoinsaturados/farmacocinética , Feminino , Fluvastatina , Indóis/administração & dosagem , Indóis/química , Indóis/farmacocinética , Cristalino/química , Cristalino/efeitos dos fármacos , Lipídeos/sangue , Fígado/efeitos dos fármacos , Fígado/enzimologia , Macaca mulatta , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Fatores de TempoRESUMO
AU-rich elements found in the 3'-untranslated regions of cytokine and proto-oncogene transcripts regulate mRNA degradation and function as binding sites for the mRNA-stabilizing protein HuA and the mRNA-destabilizing protein tristetraprolin. Experiments were performed to evaluate the expression of HuA and tristetraprolin in purified human T lymphocytes and to evaluate the ability of these proteins to recognize specific AU-rich sequences. HuA is a predominantly nuclear protein that can also be found in the cytoplasm of resting T lymphocytes. Within 1 h after stimulation of T lymphocytes with anti-T cell receptor antibodies or a combination of a phorbol myristate acetate and ionomycin, an increase in cytoplasmic HuA RNA-binding activity was observed. Although absent in resting cells, cytoplasmic tristetraprolin protein was detected 3-6 h following activation. HuA recognized specific AU-rich sequences found in c-jun or c-myc mRNA that were poorly recognized by tristetraprolin. In contrast, tristetraprolin recognized an AU-rich sequence in interleukin-2 mRNA that was poorly recognized by HuA. Both HuA and tristetraprolin, however, recognized AU-rich sequences from c-fos, interleukin-3, tumor necrosis factor-alpha, and granulocyte/macrophage colony-stimulating factor mRNA. HuA may transiently stabilize a subset of AU-rich element-containing transcripts following T lymphocyte activation, and tristetraprolin may subsequently mediate their degradation.
Assuntos
Proteínas de Ligação a DNA , Proteínas Imediatamente Precoces/biossíntese , Ativação Linfocitária , Proteínas de Ligação a RNA/biossíntese , RNA/metabolismo , Linfócitos T/imunologia , Regiões 3' não Traduzidas , Sequência de Bases , Células Cultivadas , Citoplasma/metabolismo , Humanos , Proteínas Imediatamente Precoces/metabolismo , Proto-Oncogene Mas , Sondas RNA , Proteínas de Ligação a RNA/metabolismo , TristetraprolinaRESUMO
Numerous amphiphilic cationic drugs cause generalized phospholipidosis in animals; one of these drugs is the Sandoz compound 200-125, a psychotropic agent. During a 6-month toxicity study in Charles River CD rats, a dramatic increase in foamy macrophages was seen in the lungs. A follow-up experiment was done to study the pathologic basis of these changes including a reversibility phase. Generalized phospholipidosis was induced after 4 weeks of 500 mg/kg/day of 200-125 by gavage. Characteristic pulmonary lesions consisted of extensive accumulations of large pale foamy macrophages as well as granular eosinophilic extracellular material. Lipid analyses of lungs showed marked increases in phospholipids (144%) and cholesterol esters (110%) in rats treated with 200-125. Drug metabolism studies employing 14C-labeled 200-125 showed an affinity for the drug to concentrate in the lungs and lymphoreticular system (spleen, lymph nodes) as well as in the adrenals, liver, and kidney. Reversibility of the phospholipidosis was nearly complete 4 weeks after drug withdrawal. The tissue changes were characterized by transmission and scanning electron microscopy. The potential pulmonary toxicity in humans with the amphiphiles is discussed.
Assuntos
Lipidoses/induzido quimicamente , Fosfolipídeos/metabolismo , Psicotrópicos/toxicidade , Fosfatase Ácida/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Colesterol/metabolismo , Feminino , Leucócitos/efeitos dos fármacos , Lipidoses/patologia , Pulmão/patologia , Masculino , Neutrófilos/efeitos dos fármacos , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Triglicerídeos/metabolismoRESUMO
34-250 evoked hypocholesterolemic activity in the rat (14, 25, 31, 52, 112 mg/kg, po), dog (10, 20, 40 mg/kg, po), and monkey (30 mg/kg, po). Serum triglycerides were lowered in the rat and dog but not in the monkey. 34-250 increased [14C]acetate incorporation into liver cholesterol, but incorporation of 14C-labeled acetate into serum cholesterol was decreased. Desmosterol or 7-dehydro-cholesterol did not accumulate in serum of the three species, suggesting that inhibition of cholesterol biosynthesis by 34-250 possibly does not occur at a late stage. Normal fecal bile acid excretion was observed in rats, suggesting that cholesterol catabolism probably was not enhanced by 34-250. Compound 34-250-induced hypocholesterolemia may result from inhibition of hepatic release of this sterol into blood. The reversible hepatic lipidosis observed in rats is also possibly related to decreased hepatic transport and/or secretion of triglycerides. 34-250 did not cause a proliferation of hepatic microbodies; the lack of an increase in this fatty acid oxidizing organelle suggests that it may also have had a role in increased hepatic lipidosis. In dogs, a high incidence of severe cataracts with an early onset was induced by 20 and 40 mg/kg, po of 34-250 despite the lack of desmosterol or 7-dehydro-cholesterol in serum. The absence of these late stage intermediates of cholesterol biosynthesis in the serum of a test species does not preclude the occurrence of ocular toxicity.
Assuntos
Anticolesterolemiantes/toxicidade , Catarata/induzido quimicamente , Colesterol/biossíntese , Indóis/toxicidade , Lipoproteínas/sangue , Fígado/efeitos dos fármacos , Animais , Transporte Biológico/efeitos dos fármacos , Catarata/patologia , Cebus , Colesterol/sangue , Cães , Relação Dose-Resposta a Droga , Feminino , Fígado/metabolismo , Fígado/ultraestrutura , Masculino , Ratos , Ratos Endogâmicos , Especificidade da Espécie , Triglicerídeos/metabolismoRESUMO
The benzodiazepine temazepam was given to Charles River CD rats for 2 years in the diet at dosages of 10, 40, and 160 mg/kg day. An 18-month study was performed in Charles River CD-1 mice via dietary admixture at dosages of 10, 80, and 160 mg/kg/day. Mean body weights were significantly decreased for high dose rats of both sexes from Treatment Week 39 until termination. All drug treated male groups had a higher rate of mortality when compared to the male control groups, primarily due to deaths occurring between 19 to 24 months. Compound-related hepatic lipidosis accompanied by an increase in liver weights was observed at the high dose level in the 6- and 12-month and terminal sacrifices, as well as the middle dose level at the 12-month interim sacrifice. No evidence was found of compound induced carcinogenicity at any time period. Mortality for male mice was significantly higher in the two higher dose groups; this resulted from bite wounds associated with a drug-related increase in fighting behavior. An isolated finding of borderline statistical significance (p = 0.0556) was noted for hepatocellular adenomas in high dose female mice (4/100) at the 18-month terminal sacrifice. This incidence is well within the reported historical control range (0-14%). Minimal hepatoproliferative (hyperplastic nodules) and vascular effects (telangiectasis) were seen in the high dose male and female mice at the 18-month terminal sacrifice. Thus, these results were similar to those previously reported for oxazepam although meaningful effects on neoplasia did not occur with temazepam. Unlike in man, temazepam is primarily metabolized to oxazepam in the mouse and thus these results are not adverse with regard to human safety evaluation.
Assuntos
Ansiolíticos/toxicidade , Carcinógenos , Temazepam/toxicidade , Animais , Peso Corporal/efeitos dos fármacos , Dieta , Ingestão de Alimentos/efeitos dos fármacos , Feminino , Neoplasias Hepáticas/induzido quimicamente , Masculino , Camundongos , Neoplasias Experimentais/induzido quimicamente , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Fatores Sexuais , Especificidade da Espécie , Fatores de TempoRESUMO
Escherichia coli biofilms on two polyethylene disks were implanted subcutaneously into rabbits receiving systemic gentamicin. Ultrasound was applied for 24 h to one disk. Both disks were removed, and viable bacteria were counted. Pulsed ultrasound significantly reduced bacterial viability below that of nontreated biofilms without damage to the skin.
Assuntos
Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Gentamicinas/farmacologia , Ultrassom , Animais , Biofilmes/crescimento & desenvolvimento , Escherichia coli/crescimento & desenvolvimento , Infecções por Escherichia coli/microbiologia , Infecções Relacionadas à Prótese/microbiologia , CoelhosRESUMO
Biofilm infections are a common complication of prosthetic devices in humans. Previous in vitro research has determined that low-frequency ultrasound combined with aminoglycoside antibiotics is an effective method of killing biofilms. We report the development of an in vivo model to determine if ultrasound enhances antibiotic action. Two 24-h-old Escherichia coli (ATCC 10798) biofilms grown on polyethylene disks were implanted subcutaneously on the backs of New Zealand White female rabbits, one on each side of the spine. Low-frequency (28.48-kHz) and low-power-density (100- and 300-mW/cm2) continuous ultrasound treatment was applied for 24 h with and without systemic administration of gentamicin. The disks were then removed, and the number of viable bacteria on each disk was determined. At the low ultrasonic power used in this study, exposure to ultrasound only (no gentamicin) caused no significant difference in bacterial viability. In the presence of antibiotic, there was a significant reduction due to 300-mW/cm2 ultrasound (P = 0.0485) but no significant reduction due to 100-mW/cm2 ultrasound. Tissue damage to the skin was noted at the 300-mW/cm2 treatment level. Further development of this technique has promise in treatment of clinical implant infections.